A phase II trial of metformin and fluorouracil (MetFU) for patients (pts) with metastatic colorectal cancer (mCRC) refractory to standard treatment.
Vanessa Costa Miranda
No relevant relationships to disclose
Luiza Dib Faria
No relevant relationships to disclose
Maria Ignez Freitas Melro Braghiroli
No relevant relationships to disclose
Monica Jacobs
No relevant relationships to disclose
Jorge Sabbaga
No relevant relationships to disclose
Paulo Marcelo Hoff
No relevant relationships to disclose
Rachel Pimenta Riechelmann
No relevant relationships to disclose